11 Diabetes, Obesity and Metabolism GI tolerability of incretin therapiesReview of gastrointestinal side effects (nausea, GI discomfort) of GLP-1-based therapies and titration strategies
7l), acute (10-minute) stimulation of WT INS-1 832/3 cells with exendin-4 triggered increased mitophagy, assessed using an mKeima-based assay, an effect not present following SPHKAP downregulation (Fig
Thus, GLP-1 medications were associated with lowering the risk of developing any AMD after five years of treatment in patients without any pre-existing AMD
Furthermore, other benefits include reduction in serious liver-related morbidities and all-cause mortality [57]
SAM is synthesized from the essential amino acid, methionine
doi:10.2147/DMSO.S451129 36